文献速递精神分裂症与精神病性障碍儿童青少年精神

兴奋/抑制失衡与22q11.2缺失综合征伴精神病性症状者的海马萎缩相关

Excitatory/Inhibitory Imbalance Underlies Hippocampal Atrophy in Individuals With 22q11.2 Deletion Syndrome With Psychotic Symptoms.
PubMed 文献 · Biol Psychiatry · 2023-04-01

该研究在52名22q11.2缺失携带者和42名对照中,用MEGA-PRESS序列测量前扣带回、颞上回和海马区的Glx与GABA+浓度,并纵向采集T1加权图像提取海马体积。结果发现携带者海马和颞上回Glx升高、海马GABA+降低,伴精神病性症状的携带者海马Glx进一步升高,且海马萎缩与Glx升高显著相关。

要点

  • 22q11.2缺失携带者海马和颞上回Glx升高、海马GABA+降低。
  • 伴精神病性症状的携带者海马Glx浓度进一步升高。
  • 海马萎缩更明显与携带者海马Glx水平升高显著相关。

核心结论

  • 22q11.2缺失携带者颞叶结构存在兴奋/抑制失衡,伴精神病性症状者海马Glx进一步升高并与海马萎缩相关。
  • 结果支持谷氨酸水平异常升高通过兴奋性毒性导致海马萎缩的假说。

研究设计与样本

  • 研究纳入52名22q11.2缺失携带者和42名对照参与者。
  • 使用MEGA-PRESS序列和Gannet工具箱估计前扣带回、颞上回和海马区的Glx与GABA+浓度。
  • 纵向采集T1加权图像并用FreeSurfer版本6处理提取海马体积。
  • 对伴精神病性症状的缺失携带者进行亚组分析。

主要发现

  • 前扣带回未见差异,但缺失携带者海马和颞上回Glx水平高于对照,海马GABA+水平低于对照。
  • 伴精神病性症状的缺失携带者海马Glx浓度更高。
  • 缺失携带者海马萎缩更明显与海马Glx水平升高显著相关。

临床怎么用

  • 提示海马谷氨酸水平可能作为22q11.2缺失携带者精神病性症状及海马萎缩的机制相关指标。
  • 支持谷氨酸兴奋性毒性作为遗传高风险个体海马萎缩的潜在解释。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Abnormal neurotransmitter levels have been reported in individuals at high risk for schizophrenia, leading to a shift in the excitatory/inhibitory balance. However, it is unclear whether these alterations predate the onset of clinically relevant symptoms. Our aim was to explore in vivo measures of excitatory/inhibitory balance in 22q11.2 deletion carriers, a population at genetic risk for psychosis. METHODS: Glx (glutamate+glutamine) and GABA+ (gamma-aminobutyric acid with macromolecules and homocarnosine) concentrations were estimated in the anterior cingulate cortex, superior temporal cortex, and hippocampus using the Mescher-Garwood point-resolved spectroscopy (MEGA-PRESS) sequence and the Gannet toolbox in 52 deletion carriers and 42 control participants. T1-weighted images were acquired longitudinally and processed with FreeSurfer version 6 to extract hippocampal volume. Subgroup analyses were conducted in deletion carriers with psychotic symptoms. RESULTS: While no differences were found in the anterior cingulate cortex, deletion carriers had higher levels of Glx in the hippocampus and superior temporal cortex and lower levels of GABA+ in the hippocampus than control participants. We additionally found a higher Glx concentration in the hippocampus of deletion carriers with psychotic symptoms. Finally, more pronounced hippocampal atrophy was significantly associated with increased Glx levels in deletion carriers. CONCLUSIONS: We provide evidence for an excitatory/inhibitory imbalance in temporal brain structures of deletion carriers, with a further hippocampal Glx increase in individuals with psychotic symptoms that was associated with hippocampal atrophy. These results are in line with theories proposing abnormally enhanced glutamate levels as a mechanistic explanation for hippocampal atrophy via excitotoxicity. Our results highlight a central role of glutamate in the hippocampus of individuals at genetic risk for schizophrenia.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Mancini V, Saleh MG, Delavari F, et al. Excitatory/Inhibitory Imbalance Underlies Hippocampal Atrophy in Individuals With 22q11.2 Deletion Syndrome With Psychotic Symptoms. Biol Psychiatry. 2023. PMID: 37011759. doi:10.1016/j.biopsych.2023.03.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。